Domicilium Real Estate Fund III LP bought ELOX

June 10, 2026 · Form 4 insider transaction

Domicilium Real Estate Fund III LP bought 238,422 shares of Eloxx Pharmaceuticals, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 7 days after the transaction.

Direction
Acquired (buy-side)
Shares
238,422
Price
N/A
Total value
N/A
Role
Securitycommon stock, $0.01 par value per share
Transaction codeJ: J
Transaction dateJune 10, 2026
Filing dateJune 17, 2026
Shares owned after238,422
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

Each pre-funded warrant to purchase shares of the Issuer's common stock (the "Pre-Funded Warrants") was exchanged (pursuant to the terms of the Pre-Funded Warrant) for 1 share of the Issuer's common stock.; The securities are owned directly by Domicilium Real Estate Fund III LP (the "Fund") and may be deemed to be indirectly beneficially owned by (i) Domicilium Capital Partners LLC, ("Domicilium"), the investment adviser to the Fund, (ii) Domicilium Real Estate Fund III GP LLC (the "General Partner"), the general partner of the Fund, and (ii) Daniel Simon, the managing member of Domicilium and the General Partner.

View the original Form 4 on SEC EDGAR